Form 4 holding
CFO
Gemini Therapeutics, Inc. /DE
- Security class
- Common Stock
- Shares / value
- 17,615
- Estimated value
- $1,191,655
- Report date
- 31 May 2022
- Price
- $67.65
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|